pathway

complement cascade

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about complement cascade: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

261Connections
10Hypotheses
4Analyses
50Outgoing
50Incoming
11Experiments
4Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🔀 Pathway Info
Namecomplement cascade
Key Genes/ProteinsACOX1, ADIPOQ, ADORA2A, AIF1, ALS, AMPK
Related DiseasesAlzheimer's disease
Linked Hypotheses17 hypotheses

Pathway Diagram

graph TD
    complement_cascade["complement cascade"] -->|"mediates"| GRANULOCYTE_INFILTRATION["GRANULOCYTE INFILTRATION"]
    style GRANULOCYTE_INFILTRATION fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"causes"| ASTROCYTE["ASTROCYTE"]
    style ASTROCYTE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"causes"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
    style OLIGODENDROCYTE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"active in"| microglia["microglia"]
    style microglia fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"active in"| astrocytes["astrocytes"]
    style astrocytes fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"active in"| oligodendrocytes["oligodendrocytes"]
    style oligodendrocytes fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    complement_cascade["complement cascade"] -->|"active in"| neurons["neurons"]
    style neurons fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    AQP4["AQP4"] -->|"activates"| complement_cascade["complement cascade"]
    style AQP4 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    Alzheimer_s_disease["Alzheimer's disease"] -->|"involves"| complement_cascade["complement cascade"]
    style Alzheimer_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    C3["C3"] -->|"participates in"| complement_cascade["complement cascade"]
    style C3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    neurodegeneration["neurodegeneration"] -->|"involves"| complement_cascade["complement cascade"]
    style neurodegeneration fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    multiple_sclerosis["multiple sclerosis"] -->|"involves"| complement_cascade["complement cascade"]
    style multiple_sclerosis fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    style complement_cascade fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (77)

TargetRelationTypeStr
microgliaactive_incell_type0.90
neural stem cellsactive_incell_type0.90
microglial phagocytosismediatesprocess0.90
ASTROCYTEcausesentity0.90
OLIGODENDROCYTEcausesentity0.90

Incoming (184)

SourceRelationTypeStr
AQP4activatesentity0.95
C3involved_ingene0.95
eculizumabinhibitsdrug0.90
AQP4-antibodyactivatesprotein0.90
Alzheimer's diseaseinvolvesdisease0.90

Targeting Hypotheses (10)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
SASP-Mediated Complement Cascade Amplification 0.910 neurodegeneration Senolytic therapy for age-related neurod
Complement Cascade Inhibition Synaptic Protection 0.867 neurodegeneration View
Senescent Cell ASM-Complement Cascade Intervention 0.852 neurodegeneration Lipid raft composition changes in synapt
Excessive C1q/C3/CR3 complement cascade activation initiates 0.720 neurodegeneration Synaptic pruning by microglia in neurode
Complement Cascade Specificity: Microglial C3aR Antagonism D 0.618 synaptic biology Does SPP1-mediated synaptic engulfment r
H2: Perforant Path Synapse Loss via Early Complement Cascade 0.610 neurodegeneration Entorhinal cortex layer II vulnerability
TNF-α–C1r/C1s Bridge Between NF-κB and Classical Complement 0.600 neuroinflammation How does sevoflurane-induced NF-κB activ
Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senesc 0.564 neuroinflammation What molecular mechanisms drive the tran
Combined NAMPT-Alectinib Targeting of SASP-Complement Cascad 0.549 neuroinflammation How does Alectinib, a kinase inhibitor,
Complement Cascade Activation Bridges Microglial OxPC Sensin 0.419 neuroinflammation What molecular mechanisms enable microgl

Mentioning Analyses (4)

Scientific analyses that reference this entity

Immune atlas neuroinflammation analysis in neurodegeneration

Neuroinflammation | 2026-04-03 | 4 hypotheses Top: 0.646

Synaptic pruning by microglia in neurodegeneration

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.720

Immune atlas neuroinflammation analysis in neurodegeneration

Neuroinflammation | 2026-04-02 | 0 hypotheses

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910

Experiments (11)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Mobile App-Based Intervention for BPSD in Community-Dwelling Dementia clinical dementia with behavioral and p 0.950 0.00 human patients proposed N/A
Proposed experiment from debate on Synaptic pruning by microglia in ea falsification Alzheimer's Disease 0.400 0.50 mouse proposed $200,000
Proposed experiment from debate on Senolytics targeting p16/p21+ senes falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe clinical Neurodegeneration 0.400 0.50 in_silico proposed $180,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%? clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000
Experiment: Autoimmune Hypothesis Testing in AD clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated Neurotoxic clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
cGAS-STING Pathway Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the validation Alzheimer's Disease 0.400 0.50 human proposed $2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis validation Neuroinflammation 0.400 0.50 human proposed $2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Complement, Inflammasome, and Microglial Crosstalk in Glaucoma: From Neurodegene [PMID:41900887] Chen TY, Wu N, Sun X Life (Basel) 2026 1
Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteost [PMID:40868276] Voicu V, Toader C, Șerban M, Covache-Bus Biomedicines 2025 1
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] Han QQ, Shen SY, Liang LF, Chen XR, Yu J Brain Behav Immun 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Microglia regulation of synaptic plasticity and learning and memory. [PMID:34472455] Cornell J, Salinas S, Huang HY, Zhou M Neural Regen Res 2022 1
Complement and microglia mediate early synapse loss in Alzheimer mouse models. [PMID:27033548] Hong S, Beja-Glasser VF, Nfonoyim BM, Fr Science 2016 1
First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK [PMID:41824279] ["Razak A", "Mahipal A", "Diamond JR", " Target Oncol 2026 0
Panacis Quinquefolii Radix Polysaccharides Alleviate Depressive-Like Behaviors i [PMID:41914021] Xie M, Feng L, Li R, Li M, Shen L, Zhang CNS neuroscience & therapeutic 2026 0
Vaccine-induced antibodies can limit Salmonella infection in the absence of comp [PMID:41738756] Perez-Toledo M, Aksu-Istil K, Marcial-Ju mBio 2026 0
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436] Gopalakrishna PK, Che Mohd Nassir CMN, A Cellular and molecular neurobi 2026 0
Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-C [PMID:41766448] Taxiarchis A, Pruner I Current opinion in hematology 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] Dai L, Wang J, Meng L, Zhang X, Xiao T, PLoS biology 2025 0
PDE4 inhibition alleviates HMGB1/C1q/C3-mediated excessive phagocytic pruning of [PMID:39947489] Zhao Q, Zeng C, Luo F, Xian Z, Wen H, Tu Brain, behavior, and immunity 2025 0
Botulinum Neurotoxin Induces Neurotoxic Microglia Mediated by Exogenous Inflamma [PMID:38342616] Ambrin G, Kang YJ, Van Do K, Lee C, Sing Advanced science (Weinheim, Ba 2024 0
Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric [PMID:38456789] ["Zhu J", "Wei R", "Hu G", "Wang H", "Wa Small (Weinheim an der Bergstr 2024 0
The Role of Complement Dysregulation in Glaucoma. [PMID:38396986] ["Hoppe C", "Gregory-Ksander M"] International journal of molec 2024 0
Retracted: Ginsenoside Rg1 Ameliorates Acute Renal Ischemia/Reperfusion Injury v [PMID:38234567] ["Longevity O"] Oxidative medicine and cellula 2024 0
Divergent complement system activation in two clinically distinct murine models [PMID:35958570] ["Linzey M", "DiSano K", "Welsh N", "Pac Frontiers in immunology 2022 0
ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheim [PMID:35236834] Zhao Y, Hu D, Wang R, Sun X, Ropelewski Nature communications 2022 0

Debates (4)

Multi-agent debates referencing this entity

What is the role of microglial synaptic pruning in Alzheimer's disease and other

closed · Rounds: 4 · Score: 0.68 · 2026-04-22

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia s

closed · Rounds: 4 · Score: 0.85 · 2026-04-03

Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia s

closed · Rounds: 4 · Score: 0.55 · 2026-04-02

Related Research

Hypotheses and analyses mentioning complement cascade in their description or question text

H2: Perforant Path Synapse Loss via Early Complement Cascade Activation

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview H2: Perforant Path Synapse Loss via Early Complement Cascade Activation starts from the claim th

TNF-α–C1r/C1s Bridge Between NF-κB and Classical Complement Cascade

Score: 0.600 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The TNF-α–C1r/C1s bridge represents a critical mechanistic link connecting cytoki

Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senescent Microglia to Pre

Score: 0.564 · neuroinflammation · 2026-04-15

## Mechanistic Overview Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senescent Microglia to Prevent SASP-Driven

Combined NAMPT-Alectinib Targeting of SASP-Complement Cascade

Score: 0.549 · neuroinflammation · 2026-04-16

## Mechanistic Overview Combined NAMPT-Alectinib Targeting of SASP-Complement Cascade starts from the claim that modulat

Complement Cascade Activation Bridges Microglial OxPC Sensing to Synaptic Vulner

Score: 0.419 · neuroinflammation · 2026-04-13

## Mechanistic Overview Complement Cascade Activation Bridges Microglial OxPC Sensing to Synaptic Vulnerability starts f